SKINOVATION PHARMACEUTICAL INC 10-K Cybersecurity GRC - 2024-04-15

Page last updated on April 15, 2024

SKINOVATION PHARMACEUTICAL INC reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-04-15 13:34:55 EDT.

Filings

10-K filed on 2024-04-15

SKINOVATION PHARMACEUTICAL INC filed an 10-K at 2024-04-15 13:34:55 EDT
Accession Number: 0001554795-24-000101

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity. The Company recognizes the importance of cybersecurity and the potential risks associated with cyber incidents. As a small entity with simple operations managed solely by our Chief Executive Officer (CEO), we have not implemented formal cybersecurity policies or procedures. However, we take reasonable steps to protect our electronic data and ensure the security of our operations. Given the size of our company and the nature of our operations, we believe the risk of significant cybersecurity incidents is minimal. Our CEO is responsible for overseeing all aspects of our business, including the management of cybersecurity risks. We utilize standard commercial software for business operations, which includes basic security features such as password protection and data encryption. To date, we have not experienced any material cybersecurity incidents, and there has been no known unauthorized access to our systems. We will continue to monitor our cybersecurity risk profile and take appropriate actions to safeguard our data and systems. Should any material cybersecurity incidents occur, we will assess the situation and disclose the nature, scope, and potential impact of the incident in accordance with SEC regulations.

Company Information